Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone
Authors
Gene L. Colice, George Washington UniversityFollow
Richard J. Martin, National Jewish Health, Denver, CO
Elliot Israel, Brigham and Women's Hospital, Boston, MA
Nicolas Roche, University of Paris Descartes, Paris, France
Neil Barnes, Barts Health NHS Trust, London, United Kingdom
Anne Burden, Research in Real Life, Cambridge, United Kingdom
Peter Polos, i3 Global, Basking Ridge, NJ
Paul Dorinsky, Teva Global Respiratory Research and Development, Horsham, PA
Elizabeth V. Hillyer, Research in Real Life, Cambridge, United Kingdom
Amanda J. Lee, University of Aberdeen, Aberdeen, UK
Alison Chisholm, Research in Real Life, Cambridge, United Kingdom
Julie von Ziegenweidt, Research in Real Life, Cambridge, United Kingdom
Francesca Barion, Research in Real Life, Cambridge, United Kingdom
David Price, Research in Real Life, Cambridge, United Kingdom
Document Type
Journal Article
Journal
Journal of Allergy and Clinical Immunology
Keywords
Androstadienes--administration & dosage; Anti-Asthmatic Agents--administration & dosage; Asthma--drug therapy; Beclomethasone--administration & dosage; Bronchodilator Agents--administration & dosage; Health Care Costs
APA Citation
[Epub ahead of print]
